(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -8.10%498.71M | -4.94%1.2B | -16.00%542.64M | -7.73%1.26B | --645.97M | 19.40%1.36B | --875.07M | ---- | 0.45%1.14B | 28.50%574.81M |
Special items of operating revenue | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --594.42M | ---- | ---- |
Operating income | -8.10%498.71M | -4.94%1.2B | -16.00%542.64M | -7.73%1.26B | 8.67%645.97M | 19.40%1.36B | 3.41%594.42M | 0.45%1.14B | 28.50%574.81M | |
Operating expenses | 5.32%-397.12M | 5.33%-904.8M | 14.78%-419.43M | -0.86%-955.76M | -25.62%-492.14M | -28.64%-947.64M | -6.90%-391.78M | 4.81%-736.63M | -20.51%-366.48M | |
Gross profit | -17.55%101.59M | -3.69%291.35M | -19.90%123.22M | -27.28%302.51M | -24.09%153.83M | 2.61%416.01M | -2.73%202.64M | 11.66%405.42M | 45.45%208.33M | |
Selling expenses | -5.85%-10.27M | -5.88%-19.79M | -11.64%-9.7M | 12.07%-18.69M | 29.47%-8.69M | -12.95%-21.26M | ---- | -50.49%-12.32M | 7.81%-18.82M | 65.38%-8.19M |
Administrative expenses | 4.37%-42.19M | -19.82%-95.52M | -21.59%-44.12M | 2.91%-79.72M | -2.30%-36.29M | -17.30%-82.11M | ---- | -5.42%-35.47M | -7.36%-69.99M | -36.64%-33.64M |
Research and development expenses | 24.61%-13.03M | 22.27%-33.33M | 13.72%-17.28M | 3.94%-42.88M | 14.12%-20.02M | -5.41%-44.64M | ---- | -17.41%-23.32M | 4.50%-42.35M | -23.42%-19.86M |
Profit from asset sales | ---- | ---- | ---- | ---- | ---- | -79.82%22.11K | ---- | ---- | -31.26%109.57K | --110K |
Revaluation surplus | -108.51%-58.51M | -80.17%19.02M | -580.30%-28.06M | 340.59%95.9M | 127.00%5.84M | -25.56%21.77M | ---- | ---21.63M | 995.73%29.24M | ---- |
-Changes in the fair value of other assets | -108.51%-58.51M | -80.17%19.02M | -580.30%-28.06M | 340.59%95.9M | 127.00%5.84M | -25.56%21.77M | ---- | ---21.63M | 995.73%29.24M | ---- |
Impairment and provision | -133.04%-22.84M | 33.18%-55.76M | 37.17%-9.8M | -498.18%-83.45M | -147.74%-15.6M | -5.51%-13.95M | ---- | -51.71%-6.3M | 35.65%-13.22M | -307.09%-4.15M |
-Other impairment is provision | -133.04%-22.84M | 33.18%-55.76M | 37.17%-9.8M | -498.18%-83.45M | -147.74%-15.6M | -5.51%-13.95M | ---- | -51.71%-6.3M | 35.65%-13.22M | -307.09%-4.15M |
Special items of operating profit | 119.52%9.08M | -159.35%-25.28M | -355.11%-46.52M | 21.89%42.59M | 57.83%18.24M | 10.43%34.94M | ---- | -38.54%11.56M | 13.56%31.64M | -6.34%18.8M |
Operating profit | -6.98%-42.52M | -67.44%66.42M | -143.49%-39.74M | -32.31%203.99M | -16.75%91.38M | -3.99%301.38M | 155.3M | -29.91%109.76M | 32.22%313.91M | 57.60%156.61M |
Financing cost | 3.33%-9.1M | 10.95%-17.51M | -10.13%-9.42M | -41.51%-19.66M | -17.73%-8.55M | 5.79%-13.9M | ---- | -37.74%-7.26M | -51.98%-14.75M | -23.78%-5.27M |
Special items of earning before tax | -98.02%25K | 243.42%1.22M | 677.63%1.27M | 71.54%-853.72K | -65.91%-219K | -7.72%-3M | ---- | 94.41%-132K | -5,227.01%-2.78M | -6,002.50%-2.36M |
Earning before tax | -7.72%-51.59M | -72.68%50.13M | -157.97%-47.89M | -35.51%183.47M | -19.30%82.61M | -4.01%284.48M | 154.61M | -31.29%102.37M | 30.19%296.38M | 56.57%148.98M |
Tax | -34.57%9.42M | 100.80%171.56K | 272.89%14.4M | 40.80%-21.32M | 34.57%-8.33M | 8.48%-36.01M | ---- | 38.68%-12.73M | -27.18%-39.34M | -89.99%-20.76M |
After-tax profit from continuing operations | -25.91%-42.17M | -68.98%50.3M | -145.09%-33.49M | -34.74%162.16M | -17.13%74.28M | -3.33%248.48M | -30.09%89.64M | 30.66%257.04M | 52.23%128.22M | |
Earning after tax | -25.91%-42.17M | -68.98%50.3M | -145.09%-33.49M | -34.74%162.16M | -17.13%74.28M | -3.33%248.48M | 136.57M | -30.09%89.64M | 30.66%257.04M | 52.23%128.22M |
Minority profit | -98.57%6K | -23.83%858.48K | -49.28%420K | -52.80%1.13M | 14.05%828K | -50.30%2.39M | ---- | -54.54%726K | 65.59%4.8M | 35.91%1.6M |
Profit attributable to shareholders | -24.36%-42.18M | -69.30%49.44M | -146.17%-33.91M | -34.56%161.03M | -17.38%73.46M | -2.44%246.09M | 135.12M | -29.78%88.91M | 30.14%252.23M | 52.47%126.62M |
Basic earnings per share | -25.00%-0.05 | -66.67%0.06 | -150.00%-0.04 | -33.33%0.18 | -20.00%0.08 | -3.57%0.27 | -28.57%0.1 | 27.27%0.28 | 55.56%0.14 | |
Diluted earnings per share | -25.00%-0.05 | -66.67%0.06 | -150.00%-0.04 | -33.33%0.18 | -20.00%0.08 | -3.57%0.27 | -28.57%0.1 | 27.27%0.28 | 55.56%0.14 | |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- |
Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data